Rare diseases
Investigational molecules
Locations
Back to Italy2 684 clinical trials in Novara, Italy across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in ItalyStudi-Clinici.it(opens in a new tab)A study testing cagrilintide and semaglutide for heart safety in people with cardiovascular disease
ItalyTesting Drug Combinations with GSK4381562A, GSK6097608, GSK4428859 and Dostarlimab in Patients with PD-L1 Positive Head and Neck Cancer That Has Spread or Returned
ItalyA Study Testing Zasocitinib Compared to Placebo in Adults with Nonsegmental Vitiligo to See How Well It Works and How Safe It Is
ItalyA Study Testing Imeroprubart for Adults with Primary Sjogren's Disease with Moderate to Severe Symptoms
ItalyA study comparing ziltivekimab to placebo in patients with heart failure with mildly reduced or preserved ejection fraction and inflammation
ItalyStudy of IPX203 compared to levodopa/carbidopa in patients with advanced Parkinson's disease and motor fluctuations
ItalyStudy of navenibart to prevent attacks in adults and adolescents with Hereditary Angioedema
ItalyStudy of IncobotulinumtoxinA injections compared to placebo for prevention of episodic migraine attacks
ItalyStudy of incobotulinumtoxinA injections for prevention of chronic migraine in adult patients
ItalyStudy of TAK-279 and apremilast for adults with moderate to severe plaque psoriasis
ItalyStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
ItalyStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
ItalyThe busiest research cities in the country
What the registry says about research in the country
Clinical trials focusing on hematologic malignancies and solid tumors, investigating innovative treatments for various cancer types including leukemia, breast cancer, and lung cancer.
Studies evaluating combination therapies and targeted treatments to improve patient outcomes.
Research focusing on heart failure prevention and treatment strategies, particularly exploring new drug combinations and their impact on cardiovascular outcomes.
Innovative approaches combining multiple therapeutic agents to address cardiovascular risks.
Investigations into treatments for various autoimmune disorders, including Sjögren's Syndrome and rheumatoid arthritis, with emphasis on novel therapeutic approaches.
Focus on developing targeted therapies for better disease management and patient care.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
